WORLD NEWS

Thumbnail for Johnson & Johnson announces positive results for Nipocalimab in Myasthenia Gravis treatment

27 January 2025

Johnson & Johnson announces positive results for Nipocalimab in Myasthenia Gravis treatment

Thumbnail for European Commission approves J&J’s Rybrevant-Lazcluze Combo for EGFR-mutated lung cancer

26 January 2025

European Commission approves J&J’s Rybrevant-Lazcluze Combo for EGFR-mutated lung cancer

Thumbnail for AstraZeneca invests US$570M in Canada, creating 700 jobs

24 January 2025

AstraZeneca invests US$570M in Canada, creating 700 jobs

Thumbnail for Johnson & Johnson’s Spravato gets nod as standalone treatment for depression

24 January 2025

Johnson & Johnson’s Spravato gets nod as standalone treatment for depression

Thumbnail for Shanghai Junshi Biosciences partners with LEO Pharma to expand cancer treatment access in Europe

24 January 2025

Shanghai Junshi Biosciences partners with LEO Pharma to expand cancer treatment access in Europe

Thumbnail for Moderna receives US$590M for pandemic influenza vaccine development

23 January 2025

Moderna receives US$590M for pandemic influenza vaccine development

Thumbnail for Calquence receives full FDA approval for first-line treatment of Mantle Cell Lymphoma

23 January 2025

Calquence receives full FDA approval for first-line treatment of Mantle Cell Lymphoma

Thumbnail for HHS grants US$375 M to Shionogi for development of Long-Acting Covid-19 PrEP

23 January 2025

HHS grants US$375 M to Shionogi for development of Long-Acting Covid-19 PrEP

Thumbnail for Health Canada approves FRUZAQLA for metastatic colorectal cancer treatment

22 January 2025

Health Canada approves FRUZAQLA for metastatic colorectal cancer treatment

Thumbnail for USA withdraws from WHO amid pandemic concerns

21 January 2025

USA withdraws from WHO amid pandemic concerns